Saliva and viral infections

Periodontology 2000

Volumn 70, Issue 1, 2016, Pages 93-110

  Corstjens, Paul L A M ^a   Abrams, William R ^a   Malamud, Daniel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMISTRY; HUMAN; IMMUNOLOGY; MOUTH; SALIVA; SECRETION (PROCESS); VIROLOGY; VIRUS DISEASES;

HUMANS; MOUTH; SALIVA; VIRUS DISEASES;

EID: 84949661961     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/prd.12112     Document Type: Review

References (133)

1. Amado LA, Villar LM, de Paula VS, Pinto MA, Gaspar AM. Exposure to multiple subgenotypes of hepatitis A virus during an outbreak using matched serum and saliva specimens. J Med Virol 2011: 83: 768-775.
2. Anders KL, Nguyet NM, Quyen NT, Ngoc TV, Tram TV, Gan TT, Tung NT, Dung NT, Chau NV, Wills B, Simmons CP. An evaluation of dried blood spots and oral swabs as alternative specimens for the diagnosis of dengue and screening for past dengue virus exposure. Am J Trop Med Hyg 2012: 87: 165-170.
3. Andrews E, Shores C, Hayes DN, Couch M, Southerland J, Morris D, Seaman WT, Webster-Cyriaque J. Concurrent human papillomavirus-associated tonsillar carcinoma in 2 couples. J Infect Dis 2009: 200: 882-887.
4. Archibald DW, Zon LI, Groopman JE, Allan JS, McLane MF, Essex ME. Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection. J Clin Microbiol 1986: 24: 873-875.
5. Arora G, Sheikh S, Pallagatti S, Singh B, Singh VA, Singh R. Saliva as a tool in the detection of hepatitis B surface antigen in patients. Compend Contin Educ Dent 2012: 33: 174-176, 178.
6. Balamane M, Winters MA, Dalai SC, Freeman AH, Traves MW, Israelski DM, Katzenstein DA, Klausner JD. Detection of HIV-1 in saliva: implications for case-identification, clinical monitoring and surveillance for drug resistance. Open Virol J 2010: 4: 88-93.
7. Balique F, Colson P, Raoult D. Tobacco mosaic virus in cigarettes and saliva of smokers. J Clin Virol 2012: 55: 374-376.
8. Balmaseda A, Saborio S, Tellez Y, Mercado JC, Perez L, Hammond SN, Rocha C, Kuan G, Harris E. Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies. J Clin Virol 2008: 43: 287-291.
9. Balogun MA, Parry JV, Mutton K, Okolo C, Benons L, Baxendale H, Hardiman T, Boxall EH, Sira J, Brown M, Barnett S, Gungabissoon U, Williams A, Kelly DA, Vijeratnam S, Ijaz S, Taylor B, Teo CG, Ramsay ME. Hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of England. Epidemiol Infect 2013: 141: 916-925.
10. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J. The women's interagency HIV study WIHS collaborative study group. Epidemiology 1998: 9: 117-125.
11. Baron S, Poast J, Cloyd MW. Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes. Arch Intern Med 1999: 159: 303-310.
12. Baron S, Poast J, Richardson CJ, Nguyen D, Cloyd M. Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism. J Infect Dis 2000: 181: 498-504.
13. Barr CE, Miller LK, Lopez MR, Croxson TS, Schwartz SA, Denman H, Jandorek R. Recovery of infectious HIV-1 from whole saliva. J Am Dent Assoc 1992: 123: 36-37, 39-48; discussion 38.
14. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007: 196: S142-S147.
15. Beachler DC, D'Souza G. Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol 2013: 25: 503-510.
16. Beachler DC, D'Souza G, Sugar EA, Xiao WH, Gillison ML. Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis 2013: 208: 330-339.
17. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Britt WJ, Fowler KB. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 2011: 364: 2111-2118.
18. Buisman AM, Abbink F, Schepp RM, Sonsma JA, Herremans T, Kimman TG. Preexisting poliovirus-specific IgA in the circulation correlates with protection against virus excretion in the elderly. J Infect Dis 2008: 197: 698-706.
19. Carbone I, Lazzarotto T, Ianni M, Porcellini E, Forti P, Masliah E, Gabrielli L, Licastro F. Herpes virus in Alzheimer's disease: relation to progression of the disease. Neurobiol Aging 2014: 35: 122-129.
20. Chase BA, Johnston SA, Legutki JB. Evaluation of biological sample preparation for immunosignature-based diagnostics. Clin Vaccine Immunol 2012: 19: 352-358.
21. Chen KM, Stephen JK, Ghanem T, Stachler R, Gardner G, Jones L, Schweitzer VP, Hall F, Divine G, Worsham MJ. Human papilloma virus prevalence in a multiethnic screening population. Otolaryngol Head Neck Surg 2013: 148: 436-442.
22. Chen Z, Abrams WR, Geva E, de Dood CJ, Gonzalez JM, Tanke HJ, Niedbala RS, Zhou P, Malamud D, Corstjens PL. Development of a generic microfluidic device for simultaneous detection of antibodies and nucleic acids in oral fluids. Biomed Res Int 2013: 2013: 543294.
23. Chene A, Nylen S, Donati D, Bejarano MT, Kironde F, Wahlgren M, Falk KI. Effect of acute Plasmodium falciparum malaria on reactivation and shedding of the eight human herpes viruses. PLoS One 2011: 6: e26266.
24. Cheval J, Sauvage V, Frangeul L, Dacheux L, Guigon G, Dumey N, Pariente K, Rousseaux C, Dorange F, Berthet N, Brisse S, Moszer I, Bourhy H, Manuguerra CJ, Lecuit M, Burguiere A, Caro V, Eloit M. Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol 2011: 49: 3268-3275.
25. Committee on Pediatric AIDS. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics 2008: 122: 1127-1134.
26. Coppenhaver DH, Sriyuktasuthwoo P, Baron S, Barr CE, Qureshi MN. Correlation of nonspecific antiviral activity with the ability to isolate infectious HIV-1 from saliva. N Engl J Med 1994: 330: 1314-1315.
27. Corstjens P, Zuiderwijk M, Brink A, Li S, Feindt H, Niedbala RS, Tanke H. Use of up-converting phosphor reporters in lateral-flow assays to detect specific nucleic acid sequences: a rapid, sensitive DNA test to identify human papillomavirus type 16 infection. Clin Chem 2001: 47: 1885-1893.
28. Corstjens PL, de Dood CJ, van der Ploeg-van Schip JJ, Wiesmeijer KC, Riuttamaki T, van Meijgaarden KE, Spencer JS, Tanke HJ, Ottenhoff TH, Geluk A. Lateral flow assay for simultaneous detection of cellular- and humoral immune responses. Clin Biochem 2011: 44: 1241-1246.
29. Corstjens PL, Fidder HH, Wiesmeijer KC, de Dood CJ, Rispens T, Wolbink GJ, Hommes DW, Tanke HJ. A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study. Anal Bioanal Chem 2013: 405: 7367-7375.
30. Corstjens PL, Li S, Zuiderwijk M, Kardos K, Abrams WR, Niedbala RS, Tanke HJ. Infrared up-converting phosphors for bioassays. IEE Proc Nanobiotechnol 2005: 152: 64-72.
31. Corstjens PLAM, de Dood CJ, Kornelis D, Jon Kon Fat EM, Wilson EA, Kariuki TM, Nyakundi RK, Loverde PT, Abrams WR, Tanke HJ, van Lieshout L, Deelder AM, van Dam GJ. Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phophor labels. Parasitology 2014: 141: 1841-1855.
32. Corstjens PLAM, Chen Z, Zuiderwijk M, Bau HH, Abrams WR, Malamud D, Sam NR, Tanke HJ. Rapid assay format for multiplex detection of humoral immune responses to infectious disease pathogens (HIV, HCV, and TB). Ann N Y Acad Sci 2007: 1098: 437-445.
33. Corstjens PLAM, Malamud D. Chapter 13 - Point-of-care diagnostics for infectious diseases. In: Wong DT, ed. Salivary Diagnostics. Ames: Wiley-Blackwell, 2008: 136-149.
34. Corstjens PLAM, Abrams WR, Malamud D. Detecting viruses by using salivary diagnostics. J Am Dent Assoc 2012: 143: 12S-18S.
35. Crawford DH. Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001: 356: 461-473.
36. Crepin P, Audry L, Rotivel Y, Gacoin A, Caroff C, Bourhy H. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J Clin Microbiol 1998: 36: 1117-1121.
37. Crowcroft NS, Vyse A, Brown DW, Strachan DP. Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh Scotland. J Epidemiol Community Health 1998: 52: 101-104.
38. Cubie HA, Cuschieri K. Understanding HPV tests and their appropriate applications. Cytopathology 2013: 24: 289-308.
39. de Franca TR, de Albuquerque Tavares CA, Gomes VB, Gueiros LA, Porter SR, Leao JC. Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1. Clin Oral Investig 2012: 16: 659-664.
40. Dietrich EA, Gebhard KH, Fasching CE, Giacaman RA, Kappes JC, Ross KF, Herzberg MC. Short communication: HIV type 1 escapes inactivation by saliva via rapid escape into oral epithelial cells. AIDS Res Hum Retroviruses 2012: 28: 1574-1578.
41. Drosten C, Chiu LL, Panning M, Leong HN, Preiser W, Tam JS, Gunther S, Kramme S, Emmerich P, Ng WL, Schmitz H, Koay ES. Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol 2004: 42: 2043-2047.
42. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008: 48: 148-162.
43. Faust RA, Henry K, Dailey P, Melroe H, Sullivan C, Erice A, Haase AT, Boies LR Jr. Outpatient biopsies of the palatine tonsil: access to lymphoid tissue for assessment of human immunodeficiency virus RNA titers. Otolaryngol Head Neck Surg 1996: 114: 593-598.
44. Formenty P, Leroy EM, Epelboin A, Libama F, Lenzi M, Sudeck H, Yaba P, Allarangar Y, Boumandouki P, Nkounkou VB, Drosten C, Grolla A, Feldmann H, Roth C. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006: 42: 1521-1526.
45. Foudeh AM, Fatanat DT, Veres T, Tabrizian M. Microfluidic designs and techniques using lab-on-a-chip devices for pathogen detection for point-of-care diagnostics. Lab Chip 2012: 12: 3249-3266.
46. Freel SA, Williams JM, Nelson JA, Patton LL, Fiscus SA, Swanstrom R, Shugars DC. Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. J Virol 2001: 75: 4936-4940.
47. Friedman MG. Radioimmunoassay for the detection of virus-specific IgA antibodies in saliva. J Immunol Methods 1982: 54: 203-211.
48. Fukuda H, Ichinose T, Kusama T, Sakurai R. Assessment of salivary human herpesvirus-6 and immunoglobulin A Levels in nurses working shifts. Asian Nurs Res 2008: 2: 159-165.
49. Gitman MR, Ferguson D, Landry ML. Comparison of Simplexa HSV 1 & 2 PCR with culture, immunofluorescence, and laboratory-developed TaqMan PCR for detection of herpes simplex virus in swab specimens. J Clin Microbiol 2013: 51: 3765-3769.
50. Giusti D, Burette J, Nguyen Y, Leveque N, Graesslin O, Andreoletti L. Virological diagnosis and management of two cases of congenital measles. J Med Virol 2013: 85: 2136-2138.
51. Goncalves AKS, Giraldo P, Barros-Mazon S, Gondo ML, Amaral RL, Jacyntho C. Secretory immunoglobulin A in saliva of women with oral and genital HPV infection. Eur J Obstet Gynecol Reprod Biol 2006: 124: 227-231.
52. Goodgame R. Norovirus gastroenteritis. Curr Gastroenterol Rep 2006: 8: 401-408.
53. Graves PM, Rotbart HA, Nix WA, Pallansch MA, Erlich HA, Norris JM, Hoffman M, Eisenbarth GS, Rewers M. Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract 2003: 59: 51-61.
54. Greenberg BL, Kantor ML, Jiang SS, Glick M. Patients' attitudes toward screening for medical conditions in a dental setting. J Public Health Dent 2012: 72: 28-35.
55. Griffin SM, Chen IM, Fout GS, Wade TJ, Egorov AI. Development of a multiplex microsphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens. J Immunol Methods 2011: 364: 83-93.
56. Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn 2008: 10: 279-292.
57. Gurtler L, Muhlbacher A, Michl U, Hofmann H, Paggi GG, Bossi V, Thorstensson R, Villaescusa R, Eiras A, Hernandez JM, Melchior W, Donie F, Weber B. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J Virol Methods 1998: 75: 27-38.
58. Harnett GB, Farr TJ, Pietroboni GR, Bucens MR. Frequent shedding of human herpesvirus 6 in saliva. J Med Virol 1990: 30: 128-130.
59. Hayford KT, Shomik MS, Al-Emran HM, Moss WJ, Bishai D, Levine OS. Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study. BMC Public Health 2013: 13: 1211.
60. Jin L, Vyse A, Brown DW. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull World Health Organ 2002: 80: 76-77.
61. Kato A, Imai K, Ochiai K, Ogata Y. Higher prevalence of Epstein-Barr virus DNA in deeper periodontal pockets of chronic periodontitis in Japanese patients. PLoS One 2013: 8: e71990.
62. Katz D, Herrera MI, Cuevas L, Santamaria I, Casado C, Varela JM, Najera R. Detection of Hiv-P24 antigen in body-fluids by immunotrapping on Staphylococcus aureus (Cowan-1) bacteria. Gold immunolabeling and backscattered electron analysis in a scanning electron-microscope. J Virol Methods 1994: 46: 313-332.
63. Koval CE. Home testing for HIV: hopefully, a step forward. Cleve Clin J Med 2012: 79: 713-716.
64. Lazzarotto T, DalMonte P, Boccuni MC, Ripalti A, Landini MP. Lack of correlation between virus detection and serologic tests for diagnosis of active cytomegalovirus-infection in patients with aids. J Clin Microbiol 1992: 30: 1027-1029.
65. LeClair RA. Recovery of culturable tobacco mosaic virus from sputum and thoracentesis fluids obtained from cigarette smokers with a history of pulmonary disease. Am Rev Respir Dis 1967: 95: 510-511.
66. Lee SR, Kardos KW, Schiff E, Berne CA, Mounzer K, Banks AT, Tatum HA, Friel TJ, Demicco MP, Lee WM, Eder SE, Monto A, Yearwood GD, Guillon GB, Kurtz LA, Fischl M, Unangst JL, Kriebel L, Feiss G, Roehler M. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. J Virol Methods 2011: 172: 27-31.
67. Lee SR, Yearwood GD, Guillon GB, Kurtz LA, Fischl M, Friel T, Berne CA, Kardos KW. Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection. J Clin Virol 2010: 48: 15-17.
68. Lemoine M, Thursz M. Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas. Semin Liver Dis 2014: 34: 89-97.
69. Ly KN, Xing J, Klevens RM, Jiles RB, Holmberg SD. Causes of death and characteristics of decedents with viral hepatitis, United States, 2010. Clin Infect Dis 2014: 58: 40-49.
70. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012: 156: 271-278.
71. Mach AJ, Adeyiga OB, Di Carlo D. Microfluidic sample preparation for diagnostic cytopathology. Lab Chip 2013: 13: 1011-1026.
72. Madhusudana SN, Paul JP, Abhilash VK, Suja MS. Rapid diagnosis of rabies in humans and animals by a dot blot enzyme immunoassay. Int J Infect Dis 2004: 8: 339-345.
73. Malamud D, Bau H, Niedbala S, Corstjens P. Point detection of pathogens in oral samples. Adv Dent Res 2005: 18: 12-16.
74. Malamud D, Wahl SM. The mouth: a gateway or a trap for HIV? AIDS 2010: 24: 5-16.
75. Mancuso R, Baglio F, Cabinio M, Calabrese E, Hernis A, Nemni R, Clerici M. Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer's disease. J Alzheimers Dis 2014: 38: 741-745.
76. Mattison K. Norovirus as a foodborne disease hazard. Adv Food Nutr Res 2011: 62: 1-39.
77. Mbopi-Keou FX, Legoff J, Piketty C, Hocini H, Malkin JE, Inoue N, Scully CM, Porter SR, Teo CG, Belec L. Salivary production of IgA and IgG to human herpes virus 8 latent and lytic antigens by patients in whom Kaposi's sarcoma has regressed. AIDS 2004: 18: 338-340.
78. Miklossy J. Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med 2011: 13: e30.
79. Moore BE, Flaitz CM, Coppenhaver DH, Nichols M, Kalmaz GD, Bessman JD, Cloyd MW, Lynch DP, Prabhakar BS, Baron S. HIV recovery from saliva before and after dental treatment: inhibitors may have critical role in viral inactivation. J Am Dent Assoc 1993: 124: 67-74.
80. Morissette G, Flamand L. Herpesviruses and chromosomal integration. J Virol 2010: 84: 12100-12109.
81. Morris-Cunnington MC, Edmunds WJ, Miller E, Brown DW. A novel method of oral fluid collection to monitor immunity to common viral infections. Epidemiol Infect 2004: 132: 35-42.
82. Nagaraj T, Vasanth JP, Desai A, Kamat A, Madhusudana SN, Ravi V. Ante mortem diagnosis of human rabies using saliva samples: comparison of real time and conventional RT-PCR techniques. J Clin Virol 2006: 36: 17-23.
83. Nagashunmugam T, Malamud D, Davis C, Abrams WR, Friedman HM. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. J Infect Dis 1998: 178: 1635-1641.
84. O'Connell RJ, Merritt TM, Malia JA, VanCott TC, Dolan MJ, Zahwa H, Bradley WP, Branson BM, Michael NL, De Witt CC. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol 2003: 41: 2153-2155.
85. O'Connell T, Thornton L, O'Flanagan D, Staines A, Connell J, Dooley S, McCormack G. Oral fluid collection by post for viral antibody testing. Int J Epidemiol 2001: 30: 298-301.
86. O'Shea S, Cordery M, Barrett WY, Richman DD, Bradbeer C, Banatvala JE. HIV excretion patterns and specific antibody responses in body fluids. J Med Virol 1990: 31: 291-296.
87. Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013: 56: 1363-1369.
88. Page-Shafer K, Shiboski CH, Osmond DH, Dilley J, McFarland W, Shiboski SC, Klausner JD, Balls J, Greenspan D, Greenspan JS. Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men. AIDS 2002: 16: 2350-2352.
89. Page-Shafer K, Sweet S, Kassaye S, Ssali C. (C2) Saliva, breast milk, and mucosal fluids in HIV transmission. Adv Dent Res 2006: 19: 152-157.
90. Park KS, Jeong HS, Baek KA, Lee CG, Park SM, Park JS, Choi YJ, Choi HJ, Cheon DS. Genetic analysis of norovirus GII.4 variants circulating in Korea in 2008. Arch Virol 2010: 155: 635-641.
91. Phuapradit P, Varavithya W, Vathanophas K, Sangchai R, Podhipak A, Suthutvoravut U, Nopchinda S, Chantraruksa V, Haschke F. Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai 1999: 82(Suppl 1): S43-S48.
92. Pilcher CD, Louie B, Facente S, Keating S, Hackett J Jr, Vallari A, Hall C, Dowling T, Busch MP, Klausner JD, Hecht FM, Liska S, Pandori MW. Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One 2013: 8: e80629.
93. Poloni TR, Oliveira AS, Alfonso HL, Galvao LR, Amarilla AA, Poloni DF, Figueiredo LT, Aquino VH. Detection of dengue virus in saliva and urine by real time RT-PCR. Virol J 2010: 7: 22.
94. Pride DT, Salzman J, Haynes M, Rohwer F, Davis-Long C, White RA, Loomer P, Armitage GC, Relman DA. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J 2012: 6: 915-926.
95. Ramsay M, Reacher M, O'Flynn C, Buttery R, Hadden F, Cohen B, Knowles W, Wreghitt T, Brown D. Causes of morbilliform rash in a highly immunised English population. Arch Dis Child 2002: 87: 202-206.
96. Reina J, Ballesteros F, Mari M, Munar M. Evaluation of different continuous cell lines in the isolation of mumps virus by the shell vial method from clinical samples. J Clin Pathol 2001: 54: 924-926.
97. Respess RA, Cachafeiro A, Withum D, Fiscus SA, Newman D, Branson B, Varnier OE, Lewis K, Dondero TJ. Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings. J Clin Microbiol 2005: 43: 506-508.
98. Robaina TF, Mendes GS, Benati FJ, Pena GA, Silva RC, Montes MA, Janini ME, Camara FP, Santos N. Shedding of polyomavirus in the saliva of immunocompetent individuals. J Med Virol 2013: 85: 144-148.
99. Robinson JL, Lee BE, Kothapalli S, Craig WR, Fox JD. Use of throat swab or saliva specimens for detection of respiratory viruses in children. Clin Infect Dis 2008: 46: e61-e64.
100. Rota JS, Rosen JB, Doll MK, McNall RJ, McGrew M, Williams N, Lopareva EN, Barskey AE, Punsalang A Jr, Rota PA, Oleszko WR, Hickman CJ, Zimmerman CM, Bellini WJ. Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009. Clin Vaccine Immunol 2013: 20: 391-396.
101. Rune SJ, Vestergaard BF. IgA antibodies to herpes simplex virus type 1 in duodenal juice and saliva from patients with peptic ulcer and non-ulcer controls. Scand J Gastroenterol 1984: 19: 81-84.
102. Savolainen-Kopra C, Blomqvist S, Kaijalainen S, Jounio U, Juvonen R, Peitso A, Saukkoriipi A, Vainio O, Hovi T, Roivainen M. All known human rhinovirus species are present in sputum specimens of military recruits during respiratory infection. Viruses 2009: 1: 1178-1189.
103. Shiboski CH, Webster-Cyriaque JY, Ghannoum M, Greenspan JS, Dittmer D. Overview of the oral HIV/AIDS research alliance program. Adv Dent Res 2011: 23: 28-33.
104. Shirtcliff EA, Coe CL, Pollak SD. Early childhood stress is associated with elevated antibody levels to herpes simplex virus type 1. Proc Natl Acad Sci USA 2009: 106: 2963-2967.
105. Shugars DC, Alexander AL, Fu K, Freel SA. Endogenous salivary inhibitors of human immunodeficiency virus. Arch Oral Biol 1999: 44: 445-453.
106. Shugars DC, Patton LL, Freel SA, Gray LR, Vollmer RT, Eron JJ Jr, Fiscus SA. Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva. J Dent Res 2001: 80: 414-420.
107. Simani S, Fayaz A, Rahimi P, Eslami N, Howeizi N, Biglari P. Six fatal cases of classical rabies virus without biting incidents, Iran 1990-2010. J Clin Virol 2012: 54: 251-254.
108. Slots J. Oral viral infections of adults. Periodontol 2000 2009: 49: 60-86.
109. Slots J. Human viruses in periodontitis. Periodontol 2000 2010: 53: 89-110.
110. Slots J, Saygun I, Sabeti M, Kubar A. Epstein-Barr virus in oral diseases. J Periodontal Res 2006: 41: 235-244.
111. Smith BD, Drobeniuc J, Jewett A, Branson BM, Garfein RS, Teshale E, Kamili S, Weinbaum CM. Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis 2011: 204: 825-831.
112. Sosa-Jurado F, Hernandez-Galindo VL, Melendez-Mena D, Mendoza-Torres MA, Martinez-Arroniz FJ, Vallejo-Ruiz V, Reyes-Leyva J, Santos-Lopez G. Detection of hepatitis C virus RNA in saliva of patients with active infection not associated with periodontal or liver disease severity. BMC Infect Dis 2014: 14: 72.
113. Spandole S, Cimponeriu D, Toma M, Radu I, Ion D. Rapid detection of human torque teno viruses using high-resolution melting analysis. Balkan J Med Genet 2013: 16: 55-62.
114. Strauss SM, Alfano MC, Shelley D, Fulmer T. Identifying unaddressed systemic health conditions at dental visits: patients who visited dental practices but not general health care providers in 2008. Am J Public Health 2012: 102: 253-255.
115. Sugimoto S, Nagakubo S, Ito T, Tsunoda Y, Imamura S, Tamura T, Morohoshi Y, Koike Y, Fujita Y, Ito S, Fujita S, Tachikawa N, Komatsu H. A case of acute hepatitis B related to previous gynecological surgery in Japan. J Infect Chemother 2013: 19: 524-529.
116. Talukder Y, Gopal R, Andrews N, Glenn M, Breuer J, Brown D. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies. J Virol Methods 2005: 128: 162-167.
117. Tateishi K, Toh Y, Minagawa H, Tashiro H. Detection of herpes simplex virus (HSV) in the saliva from 1, 000 oral surgery outpatients by the polymerase chain reaction (PCR) and virus isolation. J Oral Pathol Med 1994: 23: 80-84.
118. Thieme T, Yoshihara P, Piacentini S, Beller M. Clinical evaluation of oral fluid samples for diagnosis of viral hepatitis. J Clin Microbiol 1992: 30: 1076-1079.
119. Tourinho RS, de Almeida AJ, Amado LA, Villar LM, Castro AR, de Paula VS. Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas? Vaccine 2012: 30: 6421-6426.
120. Uccini S, Riva E, Antonelli G, D'Offizi G, Prozzo A, Angelici A, Faggioni A, Angeloni A, Torrisi MR, Gentile M, Baroni CD, Ruco LP. The benign cystic lymphoepithelial lesion of the parotid gland is a viral reservoir in HIV type 1-infected patients. AIDS Res Hum Retroviruses 1999: 15: 1339-1344.
121. Uusi-Kerttula H, Tamminen K, Malm M, Vesikari T, Blazevic V. Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays. Microbes Infect 2014: 16: 472-480.
122. Vazquez S, Cabezas S, Perez AB, Pupo M, Ruiz D, Calzada N, Bernardo L, Castro O, Gonzalez D, Serrano T, Sanchez A, Guzman MG. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. Int J Infect Dis 2007: 11: 256-262.
123. Vinagre C, Martinez MJ, Avendano LF, Landaeta M, Pinto ME. Virology of infantile chronic recurrent parotitis in Santiago de Chile. J Med Virol 2003: 70: 459-462.
124. Visseaux B, Larrouy L, Calin R, Katlama C, Poynard T, Ratziu V, Thibault V. Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection. J Clin Virol 2013: 58: 385-390.
125. Vyse AJ, Cohen BJ, Ramsay ME. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health 2001: 115: 201-207.
126. Warrener L, Slibinskas R, Brown D, Sasnauskas K, Samuel D. Development and evaluation of a rapid immunochromatographic test for mumps-specific IgM in oral fluid specimens and use as a matrix for preserving viral nucleic acid for RT-PCR. J Med Virol 2010: 82: 485-493.
127. Weant KA, Baker SN. Review of human rabies prophylaxis and treatment. Crit Care Nurs Clin North Am 2013: 25: 225-242.
128. Weber B, Fall EH, Berger A, Doerr HW. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol 1998: 36: 2235-2239.
129. Weinberg A, Song LY, Walker R, Allende M, Fenton T, Patterson-Bartlett J, Nachman S, Kemble G, Yi TT, Defechereux P, Wara D, Read JS, Levin M. Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. J Acquir Immune Defic Syndr 2010: 55: 189-196.
130. Wilms IR, Best AM, Adler SP. Cytomegalovirus infections among African-Americans. BMC Infect Dis 2008: 8: 107.
131. Yaari A, Tovbin D, Zlotnick M, Mostoslavsky M, Shemer-Avni Y, Hanuka N, Burbea Z, Katzir Z, Storch S, Margalith M. Detection of HCV salivary antibodies by a simple and rapid test. J Virol Methods 2006: 133: 1-5.
132. Yamauchi R, Shimizu K, Kimura F, Takemura M, Suzuki K, Akama T, Kono I, Akimoto T. Virus activation and immune function during intense training in rugby football players. Int J Sports Med 2011: 32: 393-398.
133. Yap G, Sil BK, Ng LC. Use of saliva for early dengue diagnosis. PLoS Negl Trop Dis 2011: 5: e1046.